Skip to content

Cerebras 系统

US · CBRS #529 按市值排名 上市于 2026
127.21 -14.96 -10.52%
实时 - 追踪5344个代码 - 心跳于285秒前 · 2026-10-16 20:02

估值 各估值倍数与自身5年区间的对比

市净率 4.26 处于历史正常水平 第63百分位
5年平均 -93.57 · 在Semiconductors中排名第32/68
市盈率 -76.89 低于历史水平 第22百分位
5年平均 257.39 · 前瞻 -80.15
市销率 57.30 低于历史水平 第8百分位
5年平均 75.52 · 前瞻 26.73 · 在Semiconductors中排名第65/68

同业对比 Semiconductors

公司 市值 市盈率(TTM) 市净率 股息率
Cerebras 系统 (CBRS) 30.22B -59.58 3.30 0.00%
NVIDIA (NVDA) 5.16T 27.07 22.54 0.13%
Taiwan Semiconductor (TSM) 2.14T 27.43 10.78 0.84%
Broadcom (AVGO) 1.57T 41.93 15.74 0.77%
SK hynix (SKHY) 994.83B 17.76 8.12 0.00%
Micron Technology (MU) 992.56B 11.82 7.17 0.06%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★☆☆☆ 合理价值83.70 经济护城河Narrow 不确定性Extreme

当前股价高于晨星合理价值估算34.2%。

合理价值

Cerebras Systems Inc receives a 2-star quantitative star rating, reflecting our opinion that this share class is a somewhat unattractive choice, and investors should look elsewhere for more fruitful opportunities. The stock currently trades at a 96% premium over our quantitative fair value estimate of $83.70 per share; however, this estimate should be taken with a pinch of salt due to its extreme uncertainty rating.

The firm's lack of profitability weakens our valuation estimate. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. For example, the firm's sales yield of 2.4% falls in the bottom 10% globally. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which contributes to our view that shares are overvalued.

The firm's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to revenue ratio of 48.6, a core component of valuation, lies in the top 10% compared with peers globally. This overstates the long-term cash flow growth potential of the organization. This characteristic further promotes our unfavorable price/fair value ratio.

经济护城河

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

作者:Quantitative Equity Report

报价时间 2026-10-16 20:02:27 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

Cerebras 系统 讨论区 0 条评论

发表评论